Mocksville, NC, United States of America

Regina C Whitaker

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Regina C. Whitaker: Innovator in Pharmaceutical Sciences**

Introduction

Regina C. Whitaker, based in Mocksville, NC, is a notable inventor recognized for her contributions to the field of pharmaceutical sciences. With an impressive portfolio of 2 patents, her work primarily focuses on the development of compounds that target specific subtypes of nicotinic acetylcholine receptors.

Latest Patents

Whitaker's recent patents include innovative compounds known as nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes. These compounds are formulated from specific heteroaryl carboxylic acids and diazabicycloalkanes. The significance of these compounds lies in their high selectivity and binding affinity for neuronal nicotinic receptors of the α4β2 subtype within the central nervous system (CNS). They are designed to treat and prevent a variety of CNS disorders by potentially altering the receptor population in the patient’s brain, exhibiting neuroprotective effects, and minimizing adverse side effects such as heightened blood pressure and negative gastrointestinal impacts.

Career Highlights

Throughout her career, Regina C. Whitaker has been associated with companies such as Attenua, Inc. and Targacept, Inc. Her contributions have been vital in advancing pharmaceutical innovations aimed at improving patient health outcomes in the field of neuroscience.

Collaborations

Whitaker has collaborated with talented individuals such as Anatoly A. Mazurov and Lan Miao. These collaborations have likely amplified her research efforts and contributed to the successful development of her innovative patents.

Conclusion

Regina C. Whitaker exemplifies a dedicated inventor whose work has the potential to significantly impact the treatment of CNS disorders. Her innovative patents and collaborations highlight her commitment to advancing medical science and improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…